1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Autoimmune Injectables Market to 2020

Autoimmune Injectables Market to 2020

  • June 2014
  • -
  • Greystone Research Associates

In spite of the growing understanding of the underlying disease mechanisms for a host of diseases and disease families, autoimmune conditions continue to be intractable to most therapies and difficult to treat. Because of the individual genetic variability underlying the incidence and severity of autoimmune symptoms, regional variations in the market for autoimmune therapeutics can be significant. This variability is compounded by differences in treatment protocols and cultural factors, which combine to make alliance partnerships with regional players of increasing importance. Over the past two years the introduction of new and improved injectables for treating autoimmune diseases is creating new options for clinicians and patients. This optimism is being reinforced by pipeline candidates that will further the effort to improve treatment protocols for patients.


- Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential

- Assesses existing and evolving immune disease mechanisms, treatment strategies and pipeline drug candidates

- Provides data and forecasts for major autoimmune disease segments to 2020

- Evaluates regional and global opportunities for autoimmune therapeutics

Table Of Contents

Autoimmune Injectables Market to 2020
Executive Summary

Immune Modulation in Disease Therapeutics

Evolving Models of Disease and Human Health
The Immune Response in Disease Incidence, Treatment and Prevention
The Immune Cascade
Receptors, Ligands and Cell Signaling Pathways

Autoimmune Disease Therapeutics- Commercial Realities

FDA-Approved Drugs
Patient and Disease Demographics
Competitive Landscape
Factors Limiting Growth
Regulatory Factors
Cost per Dose and Managed Care
Side Effects, Black Box Warnings and Patient Compliance

Autoimmune Disease Therapeutics - Disease Segment Analysis

Multiple Sclerosis
Crohn's Disease

Autoimmune Injectables - Indications, Market Data and Forecasts

Growth Factor inhibitors
T-Cell Receptor Inhibitors
Innate Immune Cell Receptor Inhibitors
B-Cell Receptor Inhibitors
Kinase Inhibitors
Co-stimulator Inhibitors
Chemokine Receptors
Transcription Factors
Vascular Adhesion Inhibitors
Toll-like Receptors
Other Immune Factor Drug Candidates

Business Factors

Regulatory Factors
Clinical Trial Protocols and Endpoints
Alliances and Partnerships

Autoimmune Injectables- Company Profile

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hepatitis C: KOL Insight

Hepatitis C: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

As hepatitis C cures multiply, how do experts evaluate the options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus ...

Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 8085
  • Industry report
  • August 2016
  • by Firstword Pharma

How will established and emerging agents reshape the CLL treatment landscape? How do key opinion leaders (KOLs) see the future treatment paradigm for chronic lymphocytic leukaemia (CLL) shaping up? Will ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Download Unlimited Documents from Trusted Public Sources

Therapy Market in India

  • October 2016
    51 pages
  • Therapy  

  • India  

View report >

Therapy Market in Europe and the Netherlands

  • October 2016
    7 pages
  • Therapy  

    Blood Supply  

  • Europe  

View report >

Anti-Infective Market in Europe

  • October 2016
    149 pages
  • Anti-Infective  

  • Europe  


View report >

Related Market Segments :



Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.